⌘K

Login Start Free

Home/Filings/4/0001209191-20-014092

4//SEC Filing

Liu David Y 4

Accession 0001209191-20-014092

CIK 0001377121other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:46 PM ET

Size

5.6 KB

Accession

0001209191-20-014092

Insider Transaction Report

Form 4

Period: 2020-02-28

Protagonist Therapeutics, IncPTGX

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2020-02-28+70,000→ 70,000 total
Exercise: $7.80Exp: 2030-02-27→ Common Stock (70,000 underlying)

Footnotes (1)

[F1]The stock option vests in 48 equal monthly installments following the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001675881

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 5:46 PM ET
Size: 5.6 KB

View on SEC.gov